These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 21403086

  • 41. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.
    Mahfoud F, Renkin J, Sievert H, Bertog S, Ewen S, Böhm M, Lengelé JP, Wojakowski W, Schmieder R, van der Giet M, Parise H, Haratani N, Pathak A, Persu A.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):471-484. PubMed ID: 32081241
    [Abstract] [Full Text] [Related]

  • 42. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 43. First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant Hypertension.
    Chernin G, Szwarcfiter I, Scheinert D, Blessing E, Diehm N, Dens J, Walton A, Verheye S, Shetty S, Jonas M.
    J Vasc Interv Radiol; 2018 Aug 01; 29(8):1158-1166. PubMed ID: 29921526
    [Abstract] [Full Text] [Related]

  • 44. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    Symplicity HTN-2 InvestigatorsBaker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road, Central Melbourne, VIC 8008, Australia. murray.esler@bakeridi.edu.au, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M.
    Lancet; 2010 Dec 04; 376(9756):1903-9. PubMed ID: 21093036
    [Abstract] [Full Text] [Related]

  • 45. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
    Bartuś K, Sadowski J, Kapelak B, Litwinowicz R, Zajdel W, Godlewski J, Bartuś M, Zmudka K, Chrapusta A, Konstanty-Kalandyk J, Węgrzyn P, Sobotka PA.
    Kardiol Pol; 2014 Dec 04; 72(5):425-31. PubMed ID: 24408071
    [Abstract] [Full Text] [Related]

  • 46. Long-term follow-up after radio-frequency catheter-based denervation in patients with resistant hypertension.
    Skowerski M, Roleder T, Bańska-Kisiel K, Pysz P, Ochała A, Wojakowski W, Gąsior Z.
    Int J Cardiol; 2016 Jul 15; 215():472-5. PubMed ID: 27131767
    [Abstract] [Full Text] [Related]

  • 47. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
    Kiuchi MG, Chen S, Graciano ML, Carreira MA, Kiuchi T, Andrea BR, Lugon JR.
    Int J Cardiol; 2015 Jul 15; 190():29-31. PubMed ID: 25912114
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
    Id D, Kaltenbach B, Bertog SC, Hornung M, Hofmann I, Vaskelyte L, Sievert H.
    JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1085-91. PubMed ID: 24156968
    [Abstract] [Full Text] [Related]

  • 54. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.
    Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD.
    Lancet; 2014 Feb 15; 383(9917):622-9. PubMed ID: 24210779
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
    Bartuś K, Sadowski J, Kapelak B, Zajdel W, Godlewski J, Bartuś S, Bochenek M, Bartuś M, Żmudka K, Sobotka PA.
    Kardiol Pol; 2013 Feb 15; 71(2):152-8. PubMed ID: 23575708
    [Abstract] [Full Text] [Related]

  • 58. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD.
    Int J Cardiol; 2013 Oct 03; 168(3):2214-20. PubMed ID: 23453868
    [Abstract] [Full Text] [Related]

  • 59. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
    Hiremath S, Froeschl M, Ruzicka M.
    Curr Opin Cardiol; 2014 Jul 03; 29(4):336-43. PubMed ID: 24859619
    [Abstract] [Full Text] [Related]

  • 60. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
    Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G, GSR Investigators.
    Hypertension; 2015 Apr 03; 65(4):766-74. PubMed ID: 25691618
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.